Crispr Therapeutics AG (CRSP) Insider Trading
- $27,833,805.86
- $315,291,536.43
- Nov. 11, 2024
- Samarth Kulkarni
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Oct. 24, 2016 | Major Shareholder | 800,150 | $14.00 | Buy | $11,202,100.00 |
Insiders are both buying and selling Crispr Therapeutics AG stock.
The insider traders at Crispr Therapeutics AG are: Samarth Kulkarni, Rodger Novak, Kurt Von Emster, Bradley J Phd Bolzon, Corp /De/ Celgene, Tyler Dylan-Hyde, Pablo J Cagnoni, Thomas Woiwode, Lawrence Otto Klein, Vertex Pharmaceuticals (Europe, James R Kasinger, Michael John Tomsicek, Julianne Bruno, Simeon George, James R. Kasinger, Tony W Ho, Tony W. Ho, Bradley J. Phd Bolzon, Versant Venture Capital V, L.P, Raju Prasad, and Aktiengesellschaft Bayer
The most active insider trader at Crispr Therapeutics AG is Samarth Kulkarni with 33 trades.
Kurt Von Emster has sold the most Crispr Therapeutics AG stock with a total value of $68,130,025.01.
Aktiengesellschaft Bayer has bought the most Crispr Therapeutics AG stock with a total value of $23,999,976.00.
The most recent insider trade for Crispr Therapeutics AG was on Nov. 11, 2024.
The single biggest insider buy for Crispr Therapeutics AG was from Aktiengesellschaft Bayer with a total value of $11,999,988.00 on Jan. 5, 2018.
The single biggest insider sell for Crispr Therapeutics AG was from Kurt Von Emster with a total value of $35,353,500.00 on May 14, 2018.